Normal view MARC view ISBD view

Filing of Type-II Drug Master File for US Market

By:

Material type: Text

TextPublication details: Ahmedabad Intitute of Pharmacy, Nirma University 2018Description: 119pDDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre Reference	Reference	615.1901 PAR (Browse shelf(Opens below))	Not For Loan		PDR00508
CD/DVD	NIMA Knowledge Centre Reference	Reference	615.1901 PAR (Browse shelf(Opens below))	Not For Loan		PDR00508-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.1901 PAN Product post Approvel Change Managet : Comparative Study of Europe South Africa & Brazill	615.1901 PAN Comparative Study on Current Regulatory Requirements for Generic Synthetic Peptide Based Drug-Device Combination Products in U.S. and Europe	615.1901 PAN Comparative Study on Current Regulatory Requirements for Generic Synthetic Peptide Based Drug-Device Combination Products in U.S. and Europe	615.1901 PAR Filing of Type-II Drug Master File for US Market	615.1901 PAR Filing of Type-II Drug Master File for US Market	615.1901 PAR Development and validation of Stability Indication RP-HPLC Assay Method for Estimation of Resveratrol and Orlistat in Capsule Dosage form	615.1901 PAR Development and validation of Stability Indication RP-HPLC Assay Method for Estimation of Resveratrol and Orlistat in Capsule Dosage form	Next

Guided By Dr Nrupesh Patel , Mr. Darshn Aigal and Mr. Hiren Patel

There are no comments on this title.

to post a comment.